Detalles de la búsqueda
1.
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis.
Mol Cancer
; 23(1): 6, 2024 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38184565
2.
PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer.
Cancers (Basel)
; 14(24)2022 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36551639
3.
Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity.
J Immunother Cancer
; 10(9)2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36096528
4.
Sustained compensatory p38 MAPK signaling following treatment with MAPK inhibitors induces the immunosuppressive protein CD73 in cancer: combined targeting could improve outcomes.
Mol Oncol
; 15(12): 3299-3316, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34165921
5.
Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer.
Nat Commun
; 12(1): 5112, 2021 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34433817
6.
Human cancer evolution in the context of a human immune system in mice.
Mol Oncol
; 12(10): 1797-1810, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30120895
7.
Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer.
Nat Commun
; 12(1): 5588, 2021 Sep 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34531405
Resultados
1 -
7
de 7
1
Próxima >
>>